Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.65 |
| ▸ | GNPAT | O15228 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.49 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.45 |
| ▸ | GART | P22102 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19752290 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL14553069 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL12674214 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL23689917 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL18379212 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL24558577 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL21242888 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL23689916 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL21242878 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 | |
| SCHEMBL12673962 | 1.00 | NOD1 (0.65) | NOD1GNPATFOLH1RIMKLANAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2758426-B1 | NOVEL GLUCAGON ANALOGUES | NOVO NORDISK AS (DK) | 2019-08-07 | — | — | EP | disclosed |